National Psoriasis Foundation

Drug Pipeline

« Back to the pipeline

Company

Sienna Biopharmaceuticals

Therapeutic Approach

Topical Treatments

Indication

Itch in Psoriasis

Mechanism

skin cell inhibitor (TrkA kinase blocker)

Phase

Phase II

Get the latest research news and tips on managing your psoriasis and psoriatic arthritis.